Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Javier T. Garza"'
Publikováno v:
medRxiv
COVID-19 has affected billions of people around the world directly or indirectly. The response to the pandemic has focused on preventing the spread of the disease and improving treatment options. Diagnostic technologies have played a key role in this
Publikováno v:
RSC Advances. 9:2618-2625
Bis(2-ethylhexyl) phthalate (DEHP) is an endocrine disruptor commonly present in plastic products, such as PVC tubes and water bottles. In this work, a surface enhanced Raman spectroscopy (SERS) based aptasensor was developed and utilized for rapid,
Publikováno v:
Nanophotonics, Vol 6, Iss 4, Pp 681-701 (2017)
Point-of-care (POC) device development is a growing field that aims to develop low-cost, rapid, sensitivein-vitrodiagnostic testing platforms that are portable, self-contained, and can be used anywhere – from modern clinics to remote and low resour
Autor:
Mehdi Razavi, Javier T. Garza, B S Angie Burrer, B S Anand Ganapathy, B S Matthew Bersi, Aaron Palmer
Publikováno v:
Pacing and Clinical Electrophysiology. 37:1630-1640
Background Sternal wires are used to close the thoracic cavity and facilitate healing after median sternotomy (MS). We invented an implantable device that uses these wires as sensors to monitor cardiac electrical activity and tested its utility in co
Autor:
Javier T. Garza, Gerard L. Coté
Publikováno v:
SPIE Proceedings.
Timely detection of cardiac biomarkers is needed to diagnose acute myocardial infarction, implement the appropriate early treatment, and significantly reduce the chance of mortality. Ideally, for maximizing patient impact, a point of care device need
Publikováno v:
Analytical chemistry. 85(11)
To date, the dependent nature of the recognition and transduction mechanisms in optical glucose sensors based upon Concanavalin A (ConA) has tended to prevent the sensors’ full potential from being realized. In this paper, these mechanisms are inde
Publikováno v:
SPIE Proceedings.
Competitive binding assays based on the protein Concanavalin A (ConA) have been proposed as potential sensors for continuous glucose monitoring applications. However, ConA-based assays in the literature have primarily displayed a lack of sensitivity